Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 33% ± 17% | |
eye | 8 studies | 25% ± 9% | |
lung | 7 studies | 27% ± 8% | |
peripheral blood | 7 studies | 37% ± 16% | |
heart | 4 studies | 18% ± 2% | |
liver | 4 studies | 28% ± 7% | |
adipose | 4 studies | 26% ± 7% | |
uterus | 3 studies | 34% ± 11% | |
bone marrow | 3 studies | 24% ± 6% | |
intestine | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3894.33 | 1445 / 1445 | 100% | 19.05 | 183 / 183 |
brain | 100% | 3446.22 | 2630 / 2642 | 99% | 15.18 | 696 / 705 |
breast | 100% | 4878.24 | 459 / 459 | 98% | 16.54 | 1093 / 1118 |
lung | 100% | 4064.23 | 577 / 578 | 98% | 12.30 | 1130 / 1155 |
thymus | 100% | 4400.06 | 653 / 653 | 97% | 12.72 | 589 / 605 |
intestine | 100% | 4728.60 | 966 / 966 | 96% | 10.24 | 508 / 527 |
stomach | 100% | 3145.68 | 359 / 359 | 96% | 12.38 | 275 / 286 |
skin | 100% | 5292.83 | 1809 / 1809 | 96% | 15.55 | 453 / 472 |
ovary | 100% | 5770.08 | 180 / 180 | 95% | 9.39 | 408 / 430 |
pancreas | 98% | 1918.55 | 321 / 328 | 96% | 11.07 | 171 / 178 |
kidney | 100% | 2812.06 | 89 / 89 | 94% | 11.86 | 844 / 901 |
bladder | 100% | 3922.62 | 21 / 21 | 93% | 8.89 | 469 / 504 |
uterus | 100% | 5442.11 | 170 / 170 | 93% | 9.79 | 426 / 459 |
prostate | 100% | 3393.17 | 245 / 245 | 91% | 11.40 | 459 / 502 |
adrenal gland | 100% | 2905.77 | 258 / 258 | 89% | 8.37 | 204 / 230 |
liver | 99% | 1467.74 | 223 / 226 | 59% | 4.08 | 241 / 406 |
adipose | 100% | 4757.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 5425.11 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.56 | 1 / 1 |
blood vessel | 100% | 4390.70 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2361.53 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2279.29 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 4258.55 | 886 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 13.97 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 11.94 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 74% | 5.94 | 59 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0031297 | Biological process | replication fork processing |
GO_0006281 | Biological process | DNA repair |
GO_0048188 | Cellular component | Set1C/COMPASS complex |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | BOD1L1 |
Protein name | Biorientation of chromosomes in cell division protein 1-like 1 Biorientation of chromosomes in cell division 1 like 1 |
Synonyms | FAM44A BOD1L KIAA1327 |
Description | FUNCTION: Component of the fork protection machinery required to protect stalled/damaged replication forks from uncontrolled DNA2-dependent resection. Acts by stabilizing RAD51 at stalled replication forks and protecting RAD51 nucleofilaments from the antirecombinogenic activities of FBH1 and BLM . Does not regulate spindle orientation . . |
Accessions | H0Y9Y2 ENST00000507943.2 ENST00000482713.1 ENST00000040738.10 Q8NFC6 F8WDD0 |